Allay Therapeutics

Allay Tx is developing a drug-eluting biopolymer for sustained post-operative orthopedic pain management.

allaytx.com
Menlo Park, CA

CEO: Adam Gridley
Arboretum lead: Paul McCreadie

IN THE NEWS
September 6, 2023 in Allay Therapeutics, News Page

Allay Therapeutics Appoints Nicole Vitullo to Board Of Directors

Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation, today announced the appointment of Nicole Vitullo, venture partner at Arboretum Ventures, to…
Read More
September 15, 2021 in Allay Therapeutics, Home Page, News Page

Allay Therapeutics Completes Oversubscribed $60M Financing Led by Arboretum Ventures

Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation, today announced the completion of its oversubscribed $60M Series C financing, led by…
Read More